Health-related quality of life outcomes and economic burden of inflammatory bowel disease in Japan
作者: Kaoru YamabeRyan LiebertNatalia FloresChris L Pashos
作者单位: 1Takeda Pharmaceutical Company Limited
2Kantar Health
3Takeda Pharmaceuticals International
刊名: ClinicoEconomics and Outcomes Research, 2019, Vol.2019 (default), pp.221-232
来源数据库: Dove Journal
DOI: 10.2147/CEOR.S179892
原始语种摘要: Purpose: Previous Japanese studies have not compared health related quality of life (HRQoL), work productivity and activity impairment (WPAI), healthcare resource utilization (HRU), and costs in inflammatory bowel disease (IBD) patients with non IBD controls, leading to insufficient evidence regarding IBD’s true burden. The aim of this study was to examine the impact of IBD on patient reported outcomes and costs among Japanese adults (≥18 years).Patients and methods: This retrospective cross sectional study used data from the 2012-2014 Japan National Health and Wellness Survey (N=83,505). HRQoL (SF 36v2), WPAI (WPAI General Health Questionnaire), HRU, and annual costs were compared between respondents with IBD (n=441) and non IBD controls (n=82,944), and within IBD subtypes [Crohn’s...
全文获取路径: Dove 

  • economic 经济的
  • costs 费用
  • Japanese 日本人日语日本的
  • quality 品质
  • direct 直接的
  • controls 控制机构
  • absenteeism 旷工
  • productivity 生产能力
  • National 国民牌大客车
  • insufficient 不足的